As of 2025-07-19, the Relative Valuation of Harbin Pharmaceutical Group Co Ltd (600664.SS) is 4.10 CNY. This relative valuation is based on P/E multiples. With the latest stock price at 3.94 CNY, the upside of Harbin Pharmaceutical Group Co Ltd based on Relative Valuation is 4.0%.
The range of the Relative Valuation is 3.74 - 4.81 CNY.
| Range | Selected | |
| Trailing P/E multiples | 14.3x - 18.2x | 16.2x |
| Forward P/E multiples | 13.7x - 14.7x | 14.4x |
| Fair Price | 3.74 - 4.81 | 4.10 |
| Upside | -5.1% - 22.1% | 4.0% |
| Date | P/E |
| 2025-07-17 | 14.92 |
| 2025-07-16 | 14.66 |
| 2025-07-15 | 14.43 |
| 2025-07-14 | 14.62 |
| 2025-07-11 | 14.62 |
| 2025-07-10 | 14.54 |
| 2025-07-09 | 14.31 |
| 2025-07-08 | 14.43 |
| 2025-07-07 | 14.39 |
| 2025-07-04 | 14.54 |
| 2025-07-03 | 14.54 |
| 2025-07-02 | 14.24 |
| 2025-07-01 | 14.28 |
| 2025-06-30 | 13.94 |
| 2025-06-27 | 13.94 |
| 2025-06-26 | 13.78 |
| 2025-06-25 | 13.94 |
| 2025-06-24 | 13.94 |
| 2025-06-23 | 13.71 |
| 2025-06-20 | 13.67 |
| 2025-06-19 | 13.75 |
| 2025-06-18 | 14.01 |
| 2025-06-17 | 14.35 |
| 2025-06-16 | 14.39 |
| 2025-06-13 | 14.47 |
| 2025-06-12 | 14.85 |
| 2025-06-11 | 14.81 |
| 2025-06-10 | 14.77 |
| 2025-06-09 | 14.73 |
| 2025-06-06 | 14.43 |
| 2025-06-05 | 14.35 |
| 2025-06-04 | 14.77 |
| 2025-06-03 | 14.81 |
| 2025-05-30 | 14.50 |
| 2025-05-29 | 14.35 |
| 2025-05-28 | 13.97 |
| 2025-05-27 | 14.13 |
| 2025-05-26 | 14.01 |
| 2025-05-23 | 14.31 |
| 2025-05-22 | 14.16 |
| 2025-05-21 | 14.43 |
| 2025-05-20 | 14.58 |
| 2025-05-19 | 14.35 |
| 2025-05-16 | 14.62 |
| 2025-05-15 | 14.05 |
| 2025-05-14 | 14.16 |
| 2025-05-13 | 14.01 |
| 2025-05-12 | 13.75 |
| 2025-05-09 | 13.67 |
| 2025-05-08 | 13.78 |